Protagonist Therapeutics Eulerpool News

Protagonist Therapeutics Aktie News

Protagonist Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Protagonist Therapeutics News stellen wir hier zusammen.

• 9. Juni ·

  SeekingAlpha
  ASCO 2025: Profiling The Biggest Presentations At The Biggest Cancer Meeting
• 5. Juni ·

  Yahoo
  Exploring Three High Growth Tech Stocks In The US Market
• 1. Juni ·

  Yahoo
  Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera
• 28. Mai ·

  SeekingAlpha
  Carillon Eagle Small Cap Growth Fund Q1 2025 Commentary
• 27. Mai ·

  Yahoo
  Protagonist Therapeutics (PTGX) Rose on Positive Trial Outcome
• 21. Mai ·

  Yahoo
  Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025
• 9. Mai ·

  Yahoo
  Protagonist Announces Icotrokinra Phase 3 Data on Difficult-to-Treat Scalp and Genital Psoriasis and Preclinical Data on PN-881 Presented at the Society for Investigative Dermatology Annual Meeting
• 8. Mai ·

  Yahoo
  Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
• 16. April ·

  Yahoo
  Protagonist Therapeutics Reports Granting of Inducement Award
• 10. April ·

  Yahoo
  Icotrokinra Results Show 75% of Adolescents with Plaque Psoriasis Achieved Completely Clear Skin and Demonstrate Favorable Safety Profile with a Once Daily Pill